These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 4043656)
41. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. Ben-Ari Z; Dhillon AP; Sherlock S Hepatology; 1993 Jul; 18(1):10-5. PubMed ID: 8100797 [TBL] [Abstract][Full Text] [Related]
42. Clinical evaluation of autoantibodies to liver cell membrane specific antigen, liver specific lipoprotein, and Tamm-Horsfall glycoprotein in autoimmune chronic active hepatitis. Morichika S; Arima T; Nagashima H Gastroenterol Jpn; 1987 Feb; 22(1):24-33. PubMed ID: 3569752 [TBL] [Abstract][Full Text] [Related]
43. Lymphocyte responsiveness per unit volume of blood in patients with chronic nonalcoholic and alcoholic liver disease. Plasma inhibitory factors and functional defects of responder cells. Behrens U; Friedrich I; Vernace S; Schaffner F; Paronetto F J Clin Lab Immunol; 1982 Sep; 8(3):143-52. PubMed ID: 6982341 [No Abstract] [Full Text] [Related]
44. Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Doniach D; Roitt IM; Walker JG; Sherlock S Clin Exp Immunol; 1966 Jul; 1(3):237-62. PubMed ID: 5330183 [TBL] [Abstract][Full Text] [Related]
45. Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients. Lohse AW; Gerken G; Mohr H; Löhr HF; Treichel U; Dienes HP; Meyer zum Büschenfelde KH Z Gastroenterol; 1995 Sep; 33(9):527-33. PubMed ID: 8525656 [TBL] [Abstract][Full Text] [Related]
46. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Hashimoto E; Lindor KD; Homburger HA; Dickson ER; Czaja AJ; Wiesner RH; Ludwig J Mayo Clin Proc; 1993 Nov; 68(11):1049-55. PubMed ID: 8231268 [TBL] [Abstract][Full Text] [Related]
47. Development of autoimmune hepatitis in the setting of long-standing primary biliary cirrhosis. Angulo P; El-Amin O; Carpenter HA; Lindor KD Am J Gastroenterol; 2001 Oct; 96(10):3021-7. PubMed ID: 11693344 [TBL] [Abstract][Full Text] [Related]
48. Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease. Schott E; Witt H; Pascu M; van Boemmel F; Weich V; Bergk A; Halangk J; Müller T; Puhl G; Wiedenmann B; Berg T Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):947-51. PubMed ID: 18049163 [TBL] [Abstract][Full Text] [Related]
49. In vitro anti-mitochondrial antibody synthesis in patients with primary biliary cirrhosis. Rocklin RE; Maxwell NR; Thistle L; Kaplan MM Clin Immunol Immunopathol; 1986 Jan; 38(1):22-31. PubMed ID: 2934196 [TBL] [Abstract][Full Text] [Related]
50. Mixed types of chronic active hepatitis and primary biliary cirrhosis associated with the anti-phospholipid antibody syndrome: a case report. Saeki R; Kaneko S; Terasaki S; Unoura M; Ogino H; Wakabayashi T; Kawara S; Nakanuma Y; Kobayashi K Hepatogastroenterology; 1993 Oct; 40(5):499-501. PubMed ID: 8270244 [TBL] [Abstract][Full Text] [Related]
51. [Immune phenomena in liver diseases]. Berg PA; Klein R Z Rheumatol; 1987; 46 Suppl 1():52-60. PubMed ID: 3326362 [No Abstract] [Full Text] [Related]
52. Membranous expression of Lewis Y antigen in clustered hepatocytes in chronic viral, autoimmune, and alcoholic liver diseases but not in biliary diseases. Sasaki M; Kono N; Nakanuma Y Mod Pathol; 1994 Apr; 7(3):339-46. PubMed ID: 8058706 [TBL] [Abstract][Full Text] [Related]
53. In vitro effects of cytokines and human thyroglobulin on the induction of antibody-secreting cells in patients with auto-immune thyroid disease. Resetkova E; Morita T; Akasu F; Carayon P; Volpé R Clin Invest Med; 1993 Aug; 16(4):256-64. PubMed ID: 8306534 [TBL] [Abstract][Full Text] [Related]
54. Autoimmune diseases of the liver. Manns MP Clin Lab Med; 1992 Mar; 12(1):25-40. PubMed ID: 1563239 [TBL] [Abstract][Full Text] [Related]
55. Interleukin 2 activity in chronic liver disease and the effect of in vitro alpha-interferon. Saxena S; Nouri-Aria KT; Anderson MG; Eddleston AL; Williams R Clin Exp Immunol; 1986 Mar; 63(3):541-8. PubMed ID: 3486732 [TBL] [Abstract][Full Text] [Related]
56. Comparison of in vitro and in vivo mitogenic and polyclonal antibody and autoantibody responses to peptidoglycan, LPS, protein A, PWM, PHA and Con A in normal and autoimmune mice. Dziarski R J Clin Lab Immunol; 1985 Feb; 16(2):93-109. PubMed ID: 3886911 [TBL] [Abstract][Full Text] [Related]
57. Autoimmune hepatitis: the present status in Japan. Monna T; Kuroki T; Yamamoto S Gastroenterol Jpn; 1985 Jun; 20(3):260-72. PubMed ID: 3876252 [TBL] [Abstract][Full Text] [Related]
59. Immunological factors in the evolution of active chronic hepatitis and other autoimmune liver diseases. Smith MG; Eddleston AL; Williams R Clin Gastroenterol; 1975 May; 4(2):297-313. PubMed ID: 1092487 [No Abstract] [Full Text] [Related]
60. The effect of prednisolone in vitro on immunoglobulin production in primary biliary cirrhosis. Al-Aghbar MN; Alexander GJ; Neuberger J; Nouri-Aria KT; Eddleston AL; Williams R Clin Exp Immunol; 1986 Mar; 63(3):663-70. PubMed ID: 2940039 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]